CN113150103A - Saccharomyces cerevisiae expression recombinant fish thioredoxin and preparation method thereof - Google Patents
Saccharomyces cerevisiae expression recombinant fish thioredoxin and preparation method thereof Download PDFInfo
- Publication number
- CN113150103A CN113150103A CN202110354989.6A CN202110354989A CN113150103A CN 113150103 A CN113150103 A CN 113150103A CN 202110354989 A CN202110354989 A CN 202110354989A CN 113150103 A CN113150103 A CN 113150103A
- Authority
- CN
- China
- Prior art keywords
- rftrx
- saccharomyces cerevisiae
- pyes2
- thioredoxin
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108060008226 thioredoxin Proteins 0.000 title claims abstract description 59
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 57
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 57
- 102000002933 Thioredoxin Human genes 0.000 title claims abstract description 48
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 45
- 229940094937 thioredoxin Drugs 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 14
- 241000894006 Bacteria Species 0.000 claims abstract description 13
- 230000028327 secretion Effects 0.000 claims abstract description 7
- 238000000746 purification Methods 0.000 claims abstract description 6
- 241000588724 Escherichia coli Species 0.000 claims abstract description 5
- 239000013604 expression vector Substances 0.000 claims abstract description 5
- 238000012795 verification Methods 0.000 claims abstract description 5
- 238000012807 shake-flask culturing Methods 0.000 claims abstract description 4
- 230000001131 transforming effect Effects 0.000 claims abstract description 3
- 239000013612 plasmid Substances 0.000 claims description 33
- 239000001963 growth medium Substances 0.000 claims description 28
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 13
- 230000006698 induction Effects 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 238000001976 enzyme digestion Methods 0.000 claims description 12
- 238000010521 absorption reaction Methods 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 8
- 229960000723 ampicillin Drugs 0.000 claims description 8
- 239000002609 medium Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 229930182830 galactose Natural products 0.000 claims description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- 241001052560 Thallis Species 0.000 claims description 6
- 238000001042 affinity chromatography Methods 0.000 claims description 6
- 239000012148 binding buffer Substances 0.000 claims description 6
- 238000011084 recovery Methods 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 238000005457 optimization Methods 0.000 claims description 5
- 238000004440 column chromatography Methods 0.000 claims description 4
- 238000010276 construction Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 4
- 230000009466 transformation Effects 0.000 claims description 4
- 108020004705 Codon Proteins 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- 102000012410 DNA Ligases Human genes 0.000 claims description 3
- 108010061982 DNA Ligases Proteins 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 3
- 229920002684 Sepharose Polymers 0.000 claims description 3
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000013522 chelant Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000012149 elution buffer Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 229910001453 nickel ion Inorganic materials 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000013598 vector Substances 0.000 claims description 3
- 238000007664 blowing Methods 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims description 2
- 238000001962 electrophoresis Methods 0.000 claims description 2
- 238000009630 liquid culture Methods 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000001262 western blot Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 230000008569 process Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 16
- 239000000499 gel Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- -1 compound amino acid Chemical class 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 5
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 241001596950 Larimichthys crocea Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 239000007222 ypd medium Substances 0.000 description 2
- YFXPERMKDHJPHN-UHFFFAOYSA-N 2-(pyridin-3-ylmethyl)-7H-purin-6-amine Chemical compound Nc1nc(Cc2cccnc2)nc2nc[nH]c12 YFXPERMKDHJPHN-UHFFFAOYSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- FAEFJTCTNZTPHX-ACZMJKKPSA-N Asn-Gln-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FAEFJTCTNZTPHX-ACZMJKKPSA-N 0.000 description 1
- KWQPAXYXVMHJJR-AVGNSLFASA-N Asn-Gln-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KWQPAXYXVMHJJR-AVGNSLFASA-N 0.000 description 1
- NCFJQJRLQJEECD-NHCYSSNCSA-N Asn-Leu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O NCFJQJRLQJEECD-NHCYSSNCSA-N 0.000 description 1
- VTYQAQFKMQTKQD-ACZMJKKPSA-N Asp-Ala-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O VTYQAQFKMQTKQD-ACZMJKKPSA-N 0.000 description 1
- XWKBWZXGNXTDKY-ZKWXMUAHSA-N Asp-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O XWKBWZXGNXTDKY-ZKWXMUAHSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- MKVKKORBPTUSNX-LPEHRKFASA-N Cys-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CS)N MKVKKORBPTUSNX-LPEHRKFASA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- KCJJFESQRXGTGC-BQBZGAKWSA-N Gln-Glu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O KCJJFESQRXGTGC-BQBZGAKWSA-N 0.000 description 1
- MFHVAWMMKZBSRQ-ACZMJKKPSA-N Gln-Ser-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N MFHVAWMMKZBSRQ-ACZMJKKPSA-N 0.000 description 1
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 1
- GMAGZGCAYLQBKF-NHCYSSNCSA-N Glu-Met-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O GMAGZGCAYLQBKF-NHCYSSNCSA-N 0.000 description 1
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- PNUCWVAGVNLUMW-CIUDSAMLSA-N Leu-Cys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O PNUCWVAGVNLUMW-CIUDSAMLSA-N 0.000 description 1
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- CGUYGMFQZCYJSG-DCAQKATOSA-N Met-Lys-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O CGUYGMFQZCYJSG-DCAQKATOSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- WIVCOAKLPICYGY-KKUMJFAQSA-N Phe-Asp-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N WIVCOAKLPICYGY-KKUMJFAQSA-N 0.000 description 1
- FINLZXKJWTYYLC-ACRUOGEOSA-N Phe-His-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 FINLZXKJWTYYLC-ACRUOGEOSA-N 0.000 description 1
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 1
- GMWNQSGWWGKTSF-LFSVMHDDSA-N Phe-Thr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMWNQSGWWGKTSF-LFSVMHDDSA-N 0.000 description 1
- DIZLUAZLNDFDPR-CIUDSAMLSA-N Pro-Cys-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1 DIZLUAZLNDFDPR-CIUDSAMLSA-N 0.000 description 1
- HOTVCUAVDQHUDB-UFYCRDLUSA-N Pro-Phe-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 HOTVCUAVDQHUDB-UFYCRDLUSA-N 0.000 description 1
- SFTZTYBXIXLRGQ-JBDRJPRFSA-N Ser-Ile-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SFTZTYBXIXLRGQ-JBDRJPRFSA-N 0.000 description 1
- BKZYBLLIBOBOOW-GHCJXIJMSA-N Ser-Ile-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O BKZYBLLIBOBOOW-GHCJXIJMSA-N 0.000 description 1
- 102100036407 Thioredoxin Human genes 0.000 description 1
- WQYPAGQDXAJNED-AAEUAGOBSA-N Trp-Cys-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N WQYPAGQDXAJNED-AAEUAGOBSA-N 0.000 description 1
- GITNQBVCEQBDQC-KKUMJFAQSA-N Tyr-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O GITNQBVCEQBDQC-KKUMJFAQSA-N 0.000 description 1
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 1
- 206010047400 Vibrio infections Diseases 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 101150072359 trx gene Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of biology, and particularly relates to recombinant fish thioredoxin and a preparation method thereof, which comprise the following steps: (1) constructing a saccharomyces cerevisiae secretion expression vector pYES2/CT-MF alpha-rFTRX-His; (2) preparing and transforming pYES2/CT-MF alpha-rFTRX-His engineering bacteria; (3) shake flask culture, induced expression purification and verification of saccharomyces cerevisiae engineering bacteria containing pYES2/CT-MF alpha-rFTRX-His. The FTRX gene in the engineering bacteria prepared by the invention has the preference characteristic of saccharomyces cerevisiae, contains saccharomyces cerevisiae signal peptide, can ensure that the FTRX is secreted and expressed, greatly improves the yield of expression products, and has simple acquisition process and lower cost compared with an escherichia coli expression system and other beneficial bacteria secretion expression systems.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a preparation method of saccharomyces cerevisiae expression recombinant fish thioredoxin.
Background
Thioredoxin (TRX) is a highly conserved low molecular weight protein, an acidic small molecule protein soluble in cells, stable to heat, and having redox activity, with a molecular weight of about 12 kDa. Thioredoxin has two structural types, thioredoxin-1 and thioredoxin-2. A first structural type, mainly present in the cytoplasm and nucleus; whereas the second structural type, thioredoxin-2, is present only in mitochondria.
TRX is widely distributed in plants, bacteria, yeasts and animals, and forms a thioredoxin system (TRX system) together with Thioredoxin Reductase (TR) and reduced Nicotinyl Adenine Dinucleotide Phosphate (NADPH), so that the TRX system is an effective protein reduction system. TRX contains dithio-sulfydryl and disulfide bond in the conserved activation region, and the redox activity of TRX makes thioredoxin have the functions of maintaining stable redox state in vivo, regulating cell growth, inhibiting apoptosis, regulating gene transcription influence protein content in animal body, regulating immunity and the like.
Verification and functional identification of thioredoxin and thioredoxin reductase in large yellow croaker (Chenmennau, Zhejiang ocean university) indicate that: large yellow croaker (Larimichthys crocea) is a seawater cage culture fish which is unique in China and largest in scale in China, and is also the most popular seawater fish in domestic markets. However, with the continuous expansion of the culture scale and density of large yellow croakers, various diseases continuously outbreak in the culture process, wherein vibriosis is common, and vibrio parahaemolyticus is one of the pathogens of the diseases. Thioredoxin (Trx), Thioredoxin reductase (TrxR) and reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH) form an effective protein reduction system, namely a Thioredoxin system, can regulate the processes of cell proliferation and survival, and plays an important role in the regulation of organism redox and antioxidant defense.
Disclosure of Invention
The invention provides a method for preparing recombinant fish thioredoxin, which selects a saccharomyces cerevisiae eukaryotic expression system to perform exogenous expression on the fish thioredoxin and comprises the following steps:
(1) the construction of a saccharomyces cerevisiae secretion expression vector pYES2/CT-MF alpha-rFTRX-His specifically comprises the following steps:
artificial optimization of fish thioredoxin gene to obtain plasmid pMD 19-T-rFTRX-His;
carrying out double enzyme digestion on the plasmid pYES2/CT-MF alpha and the rFTRX-His fragment recovered from the gel to obtain a positive clone pYES2/CT-MF alpha-rFTRX-His;
(2) the preparation and transformation of pYES2/CT-MF alpha-rFTRX-His engineering bacteria specifically comprise the following steps:
preparing a common solution and a culture medium for a saccharomyces cerevisiae expression system;
respectively transforming the pYES2/CT-MF alpha-rFTRX-His and the pYES2/CT-MF alpha plasmids obtained in the step (1) into Saccharomyces cerevisiae INVSC1 competent cells, and obtaining positive clone INVSC1(pYES2/CT-MF alpha-rFTRX-His) through culture of a culture medium, PCR amplification and screening;
(3) the shake flask culture, induced expression purification and verification of the saccharomyces cerevisiae engineering bacteria containing pYES2/CT-MF alpha-rFTRX-His specifically comprise the following steps:
culturing and centrifuging the positive clone INVSC1(pYES2/CT-MF alpha-rFTRX-His) obtained in the step (2), collecting supernatant, performing column chromatography to obtain purified supernatant protein liquid, and observing specific bands through SDS-PAGE electrophoresis and Westernblot identification of a mouse anti-His monoclonal antibody, namely the saccharomyces cerevisiae expression recombinant fish thioredoxin obtained by the invention.
Further, in the step (1), the artificial optimization of the fish thioredoxin gene is performed to obtain the plasmid pMD19-T-rFTRX-His, and the specific steps are as follows:
according to the amino acid sequence of the fish thioredoxin and the preference of saccharomyces cerevisiae to codons, a saccharomyces cerevisiae preferred recombinant fish thioredoxin gene is artificially designed, and the amino acid sequence of the recombinant fish thioredoxin is shown in a sequence table 1;
the recombinant fish thioredoxin gene is inserted between Hind III enzyme cutting site and Xba I enzyme cutting site of pMD19-T Simple Vector in the sequence of FTRX-His, Hind III enzyme cutting site is arranged at the 5 'end, Xba I enzyme cutting site is arranged at the 3' end, and plasmid pMD19-T-rFTRX-His is obtained.
Further, in the step (1), double enzyme digestion is performed on plasmid pYES2/CT-MF α and rFTRX-His fragments recovered from the above gel, so as to obtain positive clone pYES2/CT-MF α -rFTRX-His, and the specific steps are as follows:
designing and synthesizing a forward primer rFTRX-His F and a reverse primer rFTRX-His R according to the sequence of the rFTRX-His gene, amplifying the rFTRX-His gene in a pMD19-T-rFTRX-His plasmid through PCR, and performing gel recovery according to the instruction of a gel recovery kit;
the purchased plasmid pYES2/CT-MF alpha and the rFTRX-His fragment recovered from the gel are subjected to double enzyme digestion by QuickCut Not I and QuickCut Xba I respectively, the rFTRX-His gene fragment and the pYES2/CT-MF alpha fragment are recovered by gel digestion respectively, then T4DNA ligase is used for connection to obtain recombinant plasmid, the recombinant plasmid is transformed into escherichia coli (DH 5), positive clones are selected on an LB plate culture medium containing ampicillin, and the positive clones are identified by bacterial liquid PCR (forward primer: FTRRX-His F; reverse primer: rFTRX-His R) and double enzyme digestion (QuickCut Not I and QuickCut Xba I) to select the positive clones pYES2/CT-MF alpha-rFTRX-His.
Further, in the step (2), a common solution and a culture medium for a saccharomyces cerevisiae expression system are prepared, and the specific method comprises the following steps:
YPD medium: dissolving peptone 20g, yeast extract 10g, and glucose 20g (20 g agar powder is added when preparing solid culture medium) in 800ml water, diluting to 1L, and autoclaving at 121 deg.C for 20 min;
SC-U liquid medium: 6.70g of yeast nitrogen-free extract, 0.15g of compound amino acid, 900ml of deionized water, autoclaving at 121 ℃ for 20min, cooling to 50 ℃, adding 100ml of 20% glucose solution for filtration sterilization, mixing uniformly, and storing at 4 ℃ for later use;
SC-U plate culture medium, 6.70g yeast nitrogen-free extract, 0.15g compound amino acid, 20g agar powder, 900ml deionized water, autoclaving at 121 ℃ for 20min, cooling to 50 ℃, adding 100ml 20% glucose solution for filtration sterilization, mixing, and storing at 4 ℃ for later use;
SC-U induction medium: 6.70g of yeast nitrogen-free extract, 0.15g of compound amino acid, 800ml of deionized water, autoclaving at 121 ℃ for 20min, cooling to 50 ℃, adding 100ml of filter-sterilized 20% glucose solution and 100ml of filter-sterilized 20% galactose solution, mixing uniformly, and storing at 4 ℃ for later use.
Further, in the step (2), the specific steps for obtaining the positive clone INVSC1(pYES2/CT-MF α -rFTRX-His) are as follows:
adding 10 mu l of pYES2/CT-MF alpha-rFTRX-His plasmid into 80 mu l of Saccharomyces cerevisiae INVSCl competent cells, blowing and sucking to mix the plasmids evenly, then transferring the cells into a precooled electric shock cup, carrying out ice bath for 5min, adjusting a Bio-Rad electric converter to a fungus level, selecting PIC, placing the electric shock cup on the Bio-Rad electric converter for electric shock, simultaneously quickly adding 500 mu l of precooled 1M sorbitol solution into the electric shock cup, mixing the solution evenly, coating an SC-U plate culture medium, carrying out inversion culture at constant temperature of 30 ℃ until a monoclonal colony grows out, preparing the Saccharomyces cerevisiae transformant containing pYES2/CT-MF alpha-rFTRX-His in the monoclonal colony, preparing bacterial liquid for PCR amplification, and screening to obtain the INVSC1/pYES2/CT-MF alpha-rFTRX-His positive clone.
Further, in the step (3), the purified supernatant protein solution is obtained by culturing, centrifuging, collecting supernatant and performing column chromatography, and the specific steps are as follows:
the positive clone INVSc1(pYES 2/CT-MF. alpha. -rFTRX-His) was picked up in 30ml of liquid SC-U medium, shake-cultured overnight at 30 ℃ and OD was measured600nmLight absorption value, inoculating appropriate amount of culture solution into 100ml SC-U induction culture medium, shake culturing overnight, and measuring OD600nmTo 0.4;
centrifuging at 4 ℃ and 1500g for 5min, collecting thalli, suspending the thalli by using 1-2 ml of SC-U induction culture medium, re-inoculating 100ml of SC-U induction culture medium, placing in 30 ℃ for shake culture for 96h, centrifuging at 4 ℃ and 15000g for 5min, collecting thalli and supernatant, and filtering the supernatant subjected to induced expression by a 0.22 mu m filter membrane;
self-packed column using chemical Sepharose TM Fast Flow Nickel ion chelate affinity chromatography packing and washing Ni with 3 column volumes of purified water2+Chelating affinity chromatography column, balancing 2-3 column volumes with Binding Buffer (pH 8.0 PBS); detecting the conductivity value and the absorption value of 280nm wavelength on line, starting to sample after the conductivity value and the absorption value are stable, and setting the flow rate of the sample pumped through the chromatographic column to be 5-6 ml/min; then, the mixture is passed through a chromatographic column by using a Binding Buffer, and the foreign protein which is not combined with the chromatographic column is washed off until the OD is reached280nmStabilizing;
eluting by an Elution Buffer (pH 8.0PBS contacting 100-300 mM Imidazole) with gradient Imidazole concentration, and collecting protein corresponding to an Elution peak, namely the saccharomyces cerevisiae expression recombinant fish thioredoxin obtained by the invention.
Furthermore, the SC-U liquid culture medium and the SC-U induction culture medium are respectively added with 2% of raffinose and 2% of galactose.
Compared with the prior art, the invention has the beneficial effects that:
1. the fish TRX gene in the engineering bacteria prepared by the invention has the preference type characteristic of saccharomyces cerevisiae, contains saccharomyces cerevisiae signal peptide, can make fish thioredoxin secrete and express, greatly improves the yield of an expression product, and has simple acquisition process and lower cost compared with an escherichia coli expression system and other beneficial bacteria secretion and expression systems.
2. At present, no research report for obtaining the recombinant fish thioredoxin through a saccharomyces cerevisiae expression system exists, so that the preparation method has very important application value.
Description of the drawings:
FIG. 1 plasmid pYES2/CT-MF α map;
description of sequence listing:
sequence table 1 amino acid sequence of recombinant fish thioredoxin of the invention
In order to better understand the present invention, the following examples are further provided to illustrate the present invention, but the present invention is not limited to the following examples.
The specific implementation mode is as follows:
the invention is further illustrated by the following examples:
example 1: construction of Saccharomyces cerevisiae secretion expression vector pYES2/CT-MF alpha-rFTRX-His
(1) Artificial optimization of fish thioredoxin genes
According to the fish thioredoxin amino acid sequence and the codon preference of saccharomyces cerevisiae, a saccharomyces cerevisiae preferred fish thioredoxin gene is artificially designed, and the recombinant fish thioredoxin amino acid sequence is shown in a sequence table 1.
The gene sequence is inserted between HindIII enzyme cutting site and XbaI enzyme cutting site of pMD19-T Simple Vector in the sequence of FTRX-His, the 5 'end of the gene sequence is connected with HindIII enzyme cutting site, the 3' end of the gene sequence is connected with XbaI enzyme cutting site, and thus, the plasmid pMD19-T-rFTRX-His is obtained.
(2) Construction of Saccharomyces cerevisiae secretion expression vector pYES2/CT-MF alpha-rFTRX-His
A forward primer rFTRX-His F and a reverse primer rFTRX-His R are synthesized according to the sequence design of the rFTRX-His gene, and the rFTRX-His gene in a pMD19-T-rFTRX-His plasmid is amplified through PCR.
The reaction system is as follows:
PCR reaction procedure: pre-denatured at 95 ℃ 5 rain; 30s at 95 ℃, 25s at 58 ℃, 30s at 72 ℃ and 35 cycles; extension at 72 ℃ for 5 min. The PCR amplification products were detected by 2.0% agarose gel electrophoresis and gel recovery was carried out according to the instructions of the Qiagen gel recovery kit.
The purchased plasmid pYES2/CT-MF α (plasmid map see FIG. 1) and the rFTRX-His fragment recovered from the above gel were double digested with QuickCut Not I and QuickCut Xba I, respectively.
The enzyme digestion reaction system is as follows:
and carrying out enzyme digestion reaction for 3h in a metal bath at 37 ℃, detecting the enzyme digestion product by 2% agarose gel electrophoresis, respectively cutting gel, recovering rFTRX-His gene fragment and pYES2/CT-MF alpha fragment, and then connecting by using T4DNA ligase.
The connection reaction system is as follows:
the reaction conditions are 16 ℃ and 14h, the recombinant plasmid is transformed into escherichia coli (DH5 alpha) by a conventional method (calcium chloride method), a positive clone is selected on an LB plate culture medium containing the ampicillin, and the positive clone is selected and identified by bacterial liquid PCR (forward primer: rFTRX-His F; reverse primer: rFTRX-His R) and double enzyme digestion (QuickCut Not I and QuickCut Xba I), and a positive clone pYES2/CT-MF alpha-rFTRX-His is selected.
Example 2: preparation and transformation of pYES2/CT-MF alpha-rFTRX-His engineering bacteria
(1) Preparation of common solution and culture medium for saccharomyces cerevisiae expression system
YPD medium: dissolving peptone 20g, yeast extract 10g, and glucose 20g (20 g agar powder is added when preparing solid culture medium) in 800ml water, diluting to 1L, and autoclaving at 121 deg.C for 20 min;
SC-U liquid medium: 6.70g of yeast nitrogen-free extract, 0.15g of compound amino acid, 900ml of deionized water, autoclaving at 121 ℃ for 20min, cooling to 50 ℃, adding 100ml of 20% glucose solution for filtration sterilization, mixing uniformly, and storing at 4 ℃ for later use;
SC-U plate culture medium, 6.70g yeast nitrogen-free extract, 0.15g compound amino acid, 20g agar powder, 900ml deionized water, autoclaving at 121 ℃ for 20min, cooling to 50 ℃, adding 100ml 20% glucose solution for filtration sterilization, mixing, and storing at 4 ℃ for later use;
SC-U induction medium: 6.70g of yeast nitrogen-free extract, 0.15g of compound amino acid, 800ml of deionized water, autoclaving at 121 ℃ for 20min, cooling to 50 ℃, adding 100ml of filter-sterilized 20% glucose solution and 100ml of filter-sterilized 20% galactose solution, mixing uniformly, and storing at 4 ℃ for later use.
(2) pYES2/CT-MF alpha-rFTRX-His transformation saccharomyces cerevisiae
The plasmid pYES2/CT-MF alpha-rFTRX-His and pYES2/CT-MF alpha are respectively transformed into Saccharomyces cerevisiae INVSC1 competent cells by adopting an electric transformation method. Mu.l of pYES2/CT-MF α -rFTRX-His plasmid was added to 80. mu.l of s.cerevisiae INVSCl competent cells, well mixed by pipetting and then transferred to a pre-cooled cuvette. Ice-bath for 5min, and wiping the outer wall of the electric shock cup. The Bio-Rad electric converter was adjusted to the fungi range, PIC option, and the cuvette was placed on the Bio-Rad electric converter for electric shock. Add 500. mu.l of pre-chilled 1M sorbitol solution quickly to the cuvette, mix well and coat the SC-U plate. And (4) carrying out inverted culture at the constant temperature of 30 ℃ until a monoclonal antibody grows out. Grown in SC-U selection medium (containing ampicillin) were Saccharomyces cerevisiae transformants containing pYES2/CT-MF α -rFTRX-His and pYES2/CT-MF α plasmids, and the clones were screened for INVSC1/pYES2/CT-MF α -rFTRX-His positive clones by PCR (forward primer: rFTRX-His F; reverse primer: rFTRX-His R) from the broth.
Example 3: shake flask culture, induced expression purification and verification of saccharomyces cerevisiae engineering bacteria containing pYES2/CT-MF alpha-rFTRX-His
Selecting positive clones INVSC1(pYES2/CT-MF alpha-rFTRX-His) and INVSC1(pYES2/CT-MF alpha) respectively in 30ml of liquid SC-U selection medium (containing 2% raffinose and ampicillin), shake-culturing at 30 deg.C overnight, and determining OD600nmLight absorption value, inoculating appropriate amount of culture solution into 100ml SC-U induction culture medium (containing 2% galactose and ampicillin), shake culturing overnight to make OD600 nmCentrifuging at 0.4 deg.C and 4 deg.C for 5min at 1500g, collecting thallus, suspending thallus with 1-2 ml SC-U induction culture medium (containing 2% galactose and ampicillin), inoculating 100ml SC-U induction culture medium (containing 2% galactose and ampicillin), shake culturing at 30 deg.C for 96 hr, centrifuging at 4 deg.C and 15000g for 5min, collecting thallus and supernatant, and filtering the supernatant with 0.22 μm filter membrane.
The column was self-packed using the GE Healthcare company chemical Sepharose TM Fast Flow Nickel ion chelate affinity chromatography packing, and the Ni was washed with 3 column volumes of purified water2+Chelating affinity chromatography column, and then Binding Buffer (pH 8)0PBS) to equilibrate 2-3 column volumes. And (3) detecting the conductivity value and the absorption value of 280nm wavelength on line, starting to sample after the conductivity value and the absorption value are both stable, and setting the flow rate of the sample pumped through the chromatographic column to be 5-6 ml/min. Then, the mixture is passed through a chromatographic column by using a Binding Buffer, and the foreign protein which is not combined with the chromatographic column is washed off until the OD is reached280nmAnd (4) stabilizing. Eluting with an Elution Buffer (pH 8.0PBS containing 100-300 mM imidazole) with gradient imidazole concentration, collecting protein corresponding to an Elution peak, and performing SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) on a protein sample in the purification process so as to analyze the purification effect.
In conclusion, the invention adopts the genetic engineering technology to express the recombinant fish thioredoxin, and finally obtains remarkable effect. The preparation method for expressing the recombinant fish thioredoxin related by the invention has the advantages of simple technology, low cost and practical application value to the breeding industry, provides a new idea for the development of feed additives in the breeding industry, has strong feasibility and greatly improves the working efficiency.
The above embodiments are merely illustrative of the technical ideas and features of the present invention, and the purpose thereof is to enable those skilled in the art to understand the contents of the present invention and implement the present invention, and not to limit the protection scope of the present invention. All equivalent changes and modifications made according to the spirit of the present invention should be covered within the protection scope of the present invention.
Sequence listing
<110> research institute of biological product industry, Inc. of Utafel, Utaki
<120> saccharomyces cerevisiae expression recombinant fish thioredoxin and preparation method thereof
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 110
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 1
Met Lys Ser Ser Ile Asp Leu Cys Ser Gln Glu Gly Phe Asp Lys Ala
1 5 10 15
Leu Ala Glu Ala Gly Asp Asn Leu Val Val Val Asp Phe Thr Ala Thr
20 25 30
Trp Cys Gly Pro Cys Gln Ser Ile Ala Pro Phe Tyr Lys Gly Leu Ser
35 40 45
Glu Asn Pro Ser Tyr Ala Lys Val Val Phe Leu Lys Val Asp Val Asp
50 55 60
Asp Ala Gln Asp Val Ala Gln Ser Cys Glu Ile Lys Cys Met Pro Thr
65 70 75 80
Phe His Phe Tyr Lys Asn Gly Lys Lys Leu Asp Asp Phe Ser Gly Ser
85 90 95
Asn Gln Ala Lys Leu Glu Glu Met Val Asn Gln Tyr Lys Asn
100 105 110
Claims (8)
1. The saccharomyces cerevisiae expression recombinant fish thioredoxin is characterized in that the amino acid sequence of the recombinant fish thioredoxin is shown in a sequence table 1.
2. The saccharomyces cerevisiae expression recombinant fish thioredoxin of claim 1, wherein the recombinant fish thioredoxin amino acid sequence is artificially designed according to the fish thioredoxin amino acid sequence and the preference of saccharomyces cerevisiae to codons.
3. A preparation method of saccharomyces cerevisiae expression recombinant fish thioredoxin is characterized by comprising the following steps:
(1) the construction of a saccharomyces cerevisiae secretion expression vector pYES2/CT-MF alpha-rFTRX-His specifically comprises the following steps:
artificial optimization of fish thioredoxin gene to obtain plasmid pMD 19-T-rFTRX-His;
carrying out double enzyme digestion on the plasmid pYES2/CT-MF alpha and the rFTRX-His fragment recovered from the gel to obtain a positive clone pYES2/CT-MF alpha-rFTRX-His;
(2) the preparation and transformation of pYES2/CT-MF alpha-rFTRX-His engineering bacteria specifically comprise the following steps:
preparing a common solution and a culture medium for a saccharomyces cerevisiae expression system;
respectively transforming the pYES2/CT-MF alpha-rFTRX-His and the pYES2/CT-MF alpha plasmids obtained in the step (1) into Saccharomyces cerevisiae INVSC1 competent cells, and obtaining positive clone INVSC1(pYES2/CT-MF alpha-rFTRX-His) through culture of a culture medium, PCR amplification and screening;
(3) the shake flask culture, induced expression purification and verification of the saccharomyces cerevisiae engineering bacteria containing pYES2/CT-MF alpha-rFTRX-His specifically comprise the following steps:
culturing and centrifuging the positive clone INVSC1(pYES2/CT-MF alpha-rFTRX-His) obtained in the step (2), collecting supernatant, performing column chromatography to obtain purified supernatant protein liquid, and observing specific bands through SDS-PAGE electrophoresis and Westernblot identification of a mouse anti-His monoclonal antibody, namely the saccharomyces cerevisiae expression recombinant fish thioredoxin obtained by the invention.
4. The method for preparing recombinant fish thioredoxin expressed by saccharomyces cerevisiae according to claim 3, wherein in the step (1), the artificial optimization of fish thioredoxin gene is performed to obtain plasmid pMD19-T-rFTRX-His, and the specific steps are as follows:
according to the amino acid sequence of the fish thioredoxin and the preference of saccharomyces cerevisiae to codons, a saccharomyces cerevisiae preferred fish thioredoxin gene is artificially designed, and the amino acid sequence of the recombinant fish thioredoxin is shown in a sequence table 1;
the recombinant fish thioredoxin gene is inserted between Hind III enzyme cutting site and Xba I enzyme cutting site of pMD19-T Simple Vector in the sequence of FTRX-His, Hind III enzyme cutting site is arranged at the 5 'end, Xba I enzyme cutting site is arranged at the 3' end, and plasmid pMD19-T-rFTRX-His is obtained.
5. The method for preparing recombinant fish thioredoxin expressed by saccharomyces cerevisiae according to claim 3, wherein in the step (1), plasmid pYES2/CT-MF α and rFTRX-His fragment recovered from the above gel are subjected to double enzyme digestion to obtain positive clone pYES2/CT-MF α -rFTRX-His, and the specific steps are as follows:
designing and synthesizing a forward primer rFTRX-His F and a reverse primer rFTRX-His R according to the sequence of the rFTRX-His gene, amplifying the rFTRX-His gene in a pMD19-T-rFTRX-His plasmid through PCR, and performing gel recovery according to the instruction of a gel recovery kit;
the purchased plasmid pYES2/CT-MF alpha and the rFTRX-His fragment recovered from the gel are subjected to double enzyme digestion by QuickCut Not I and QuickCut Xba I respectively, the rFTRX-His gene fragment and the pYES2/CT-MF alpha fragment are recovered by gel digestion respectively, then T4DNA ligase is used for connection to obtain recombinant plasmid, the recombinant plasmid is transformed into escherichia coli (DH 5), positive clones are selected on an LB plate culture medium containing ampicillin, and the positive clones are identified by bacterial liquid PCR (forward primer: FTRRX-His F; reverse primer: rFTRX-His R) and double enzyme digestion (QuickCut Not I and QuickCut Xba I) to select the positive clones pYES2/CT-MF alpha-rFTRX-His.
6. The method for preparing recombinant fish thioredoxin expressed by saccharomyces cerevisiae according to claim 3, wherein the specific steps for obtaining positive clone INVSC1(pYES2/CT-MF α -rFTRX-His) in step (2) are as follows:
adding 10 mu l of pYES2/CT-MF alpha-rFTRX-His plasmid into 80 mu l of Saccharomyces cerevisiae INVSCl competent cells, blowing and sucking to mix the plasmids evenly, then transferring the cells into a precooled electric shock cup, carrying out ice bath for 5min, adjusting a Bio-Rad electric converter to a fungus level, selecting PIC, placing the electric shock cup on the Bio-Rad electric converter for electric shock, simultaneously quickly adding 500 mu l of precooled 1M sorbitol solution into the electric shock cup, mixing the solution evenly, coating an SC-U plate culture medium, carrying out inversion culture at constant temperature of 30 ℃ until a monoclonal colony grows out, preparing the Saccharomyces cerevisiae transformant containing pYES2/CT-MF alpha-rFTRX-His in the monoclonal colony, preparing bacterial liquid for PCR amplification, and screening to obtain the INVSC1/pYES2/CT-MF alpha-rFTRX-His positive clone.
7. The method for preparing recombinant fish thioredoxin expressed by Saccharomyces cerevisiae according to claim 3, wherein in the step (3),
the purified supernatant protein liquid is obtained by culturing, centrifuging, collecting supernatant and carrying out column chromatography, and the method comprises the following specific steps:
the positive clone INVSc1(pYES 2/CT-MF. alpha. -rFTRX-His) was picked up in 30ml of liquid SC-U medium, shake-cultured overnight at 30 ℃ and OD was measured600nmLight absorption value, inoculating appropriate amount of culture solution into 100ml SC-U induction culture medium, shake culturing overnight, and measuring OD600nmTo 0.4;
centrifuging at 4 ℃ and 1500g for 5min, collecting thalli, suspending the thalli by using 1-2 ml of SC-U induction culture medium, re-inoculating 100ml of SC-U induction culture medium, placing in 30 ℃ for shake culture for 96h, centrifuging at 4 ℃ and 15000g for 5min, collecting thalli and supernatant, and filtering the supernatant subjected to induced expression by a 0.22 mu m filter membrane;
self-packed column using chemical Sepharose TM Fast Flow Nickel ion chelate affinity chromatography packing and washing Ni with 3 column volumes of purified water2+Chelating affinity chromatography column, balancing 2-3 column volumes with Binding Buffer; detecting the conductivity value and the absorption value of 280nm wavelength on line, starting to sample after the conductivity value and the absorption value are stable, and setting the flow rate of the sample pumped through the chromatographic column to be 5-6 ml/min; then, the mixture is passed through a chromatographic column by using a Binding Buffer, and the foreign protein which is not combined with the chromatographic column is washed off until the OD is reached280nmStabilizing;
and eluting by using an Elution Buffer with gradient imidazole concentration, and collecting protein corresponding to an Elution peak, namely the saccharomyces cerevisiae expression recombinant fish thioredoxin obtained by the invention.
8. The method of claim 7, wherein the SC-U liquid culture medium and the SC-U induction culture medium are supplemented with 2% raffinose and 2% galactose, respectively.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110354989.6A CN113150103A (en) | 2021-04-01 | 2021-04-01 | Saccharomyces cerevisiae expression recombinant fish thioredoxin and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110354989.6A CN113150103A (en) | 2021-04-01 | 2021-04-01 | Saccharomyces cerevisiae expression recombinant fish thioredoxin and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113150103A true CN113150103A (en) | 2021-07-23 |
Family
ID=76886047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110354989.6A Pending CN113150103A (en) | 2021-04-01 | 2021-04-01 | Saccharomyces cerevisiae expression recombinant fish thioredoxin and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113150103A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020146793A1 (en) * | 1997-02-19 | 2002-10-10 | Chiron S.P.A. , A Corporation | Expression of heterologous proteins |
| US20110129872A1 (en) * | 2009-12-01 | 2011-06-02 | Mogam Biotechnology Research Institute | Method for a production of a recombinant protein using yeast co-expression system |
| CN104480125A (en) * | 2014-12-05 | 2015-04-01 | 中国水产科学研究院南海水产研究所 | Trachinotus ovatus thioredoxin gene |
| US20170074858A1 (en) * | 1998-10-13 | 2017-03-16 | Peptide Biosciences, Inc. | Stabilizied Bioactive Peptides and Methods of Identification, Synthesis and Use |
-
2021
- 2021-04-01 CN CN202110354989.6A patent/CN113150103A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020146793A1 (en) * | 1997-02-19 | 2002-10-10 | Chiron S.P.A. , A Corporation | Expression of heterologous proteins |
| US20170074858A1 (en) * | 1998-10-13 | 2017-03-16 | Peptide Biosciences, Inc. | Stabilizied Bioactive Peptides and Methods of Identification, Synthesis and Use |
| US20110129872A1 (en) * | 2009-12-01 | 2011-06-02 | Mogam Biotechnology Research Institute | Method for a production of a recombinant protein using yeast co-expression system |
| CN104480125A (en) * | 2014-12-05 | 2015-04-01 | 中国水产科学研究院南海水产研究所 | Trachinotus ovatus thioredoxin gene |
Non-Patent Citations (3)
| Title |
|---|
| JIANG,W: ""Thioredoxin [Anabarilius grahami] GenBank: ROI47901.1"", 《GENBANK》 * |
| MENGNAN CHEN ET AL.: ""Cloning and functional characterization of thioredoxin genes from large yellow croaker Larimichthys crocea"", 《FISH AND SHELLFISH IMMUNOLOGY》 * |
| 邹向晖 等: ""人硫氧还蛋白真核载体的构建及表达"", 《中国地方病学杂质》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101235362B (en) | Composite automatic induction culture medium for expressing exogenous protein by prokaryocyte expression system | |
| CN103525790A (en) | Optimized high-temperature resistant mannanase MAN5gy, and preparation method and application thereof | |
| CN107384880A (en) | A kind of flavine monooxygenase mutant and preparation method thereof | |
| CN103173367A (en) | Engineered Saccharomyces cerevisiae producing heat-stability recombinant trypsin, and its application | |
| CN107760700A (en) | β mannase genes, recombinant expression carrier, bacterial strain, β mannases and preparation method and application | |
| CN105802943B (en) | A pullulanase chimera with improved performance and a Pichia pastoris mutant strain with high yield of the chimera | |
| CN105418755A (en) | Quick-acting insulin aspart precursor protein and preparation method for quick-acting insulin | |
| CN103160522A (en) | High-efficiency expression and purification method of aspergillus flavus uricase in Pichia pastoris | |
| CN113150103A (en) | Saccharomyces cerevisiae expression recombinant fish thioredoxin and preparation method thereof | |
| CN101280019A (en) | Fusion protein of human serum albumin and human granulocyte colony-stimulating factor mutant and its preparation | |
| CN113106076A (en) | Saccharomyces cerevisiae expression recombinant chicken thioredoxin and preparation method thereof | |
| US11319353B2 (en) | Recombinant Dermatophagoides pteronyssinus type 2 allergen protein and its preparation method and application | |
| CN116987700B (en) | Human interleukin-5 recombinant protein and preparation method thereof | |
| CN119614466A (en) | A recombinant Escherichia coli for preparing soluble EC-SOD and its application | |
| CN113106077A (en) | Preparation method of saccharomyces cerevisiae expression recombinant swine thioredoxin and application of saccharomyces cerevisiae expression recombinant swine thioredoxin in breeding industry | |
| CN111019920B (en) | High-temperature-resistant phytase mutant and coding gene and application thereof | |
| CN110592121A (en) | A highly expressed endocellulase gene and its recombinant vector and protein | |
| CN110592120A (en) | A kind of cellulase artificial synthesis gene and its protein and recombinant vector | |
| CN114317488B (en) | Phytase mutant with improved specific activity | |
| CN109957538A (en) | A kind of genetic engineering bacteria for preparing sarcosine oxidase and its preparation method and application | |
| CN113105557A (en) | Saccharomyces cerevisiae expression human rVEGF-HSA fusion protein and preparation method of standard substance thereof | |
| CN110592034B (en) | Glucose oxidase mutant and carrier and application thereof | |
| CN107653257A (en) | A kind of encoding gene, recombinant expression carrier and the application of nicotinamide mononucleotide adenylyl transferase | |
| CN110358770B (en) | A method for yeast biosynthesis of conotoxin | |
| CN109609539B (en) | Method for preparing ELABELA polypeptide from recombinant pichia pastoris |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210723 |
|
| RJ01 | Rejection of invention patent application after publication |